TGFB1 and Hepatic fibrosis: However, TCDD did not increase the deposition of collagen or the severity of liver fibrosis in CCl4-treated mice, despite increased expression of genes encoding collagen type I and the potent profibrogenic mediator, transforming growth factor-β1 (TGF-β1).